Updates in non-Melanoma Skin Cancer

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

October 25, 2023

AdventHealth

J. Dominguez-Cherit

Dana-Farber Cancer Institute

EADV 2023 Insights

M. L. Stevenson

Brian Berman

EADV 2024 Insights

N. Benmehidi

Insights from 2023 ESMO Annual Meeting

ImmunoTherapy Bridge 2023

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

C. Rodriguez

Total Health

ImmunoTherapy Bridge 2023

P. A. Ascierto

Todd Schlesinger

Insights from 2023 ASCO® Annual Meeting

AACR 2023 Conference Coverage

Yale Cancer Center

Login

Login

Join VuMedi

Updates in non-Melanoma Skin Cancer

Related Content

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024 Insights: Management of Locally Advanced Basal Cell Carcino…

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

Year in Review: Updates in Non-Melanoma Skin Cancers

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

Management of High Risk Squamous Cell Carcinoma

Basal Cell Carcinoma: Pathophysiology of the Hedgehog Pathway and In…

EADV 2024 Insights: Dermatology in Skin of Color Patients - Challeng…

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV CSCC …

Super Giant Basal Cell Carcinoma: A Comprehensive Systematic Review

Neoadjuvant IO: Non-Melanoma Skin Cancer

Fred Hutchinson Cancer Center Head & Neck Cancer Updates

2023 ASCO® Direct Philadelphia: Melanoma Updates

Non-Melanoma Skin Cancers

PD-1 Inhibitors for Advanced Basal Cell Carcinoma and Squamous Cell …

ASCO® 2023 Insights: "To Treat or Not to Treat - Challenging Scenari…

ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplimab in …

Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Ant…

Immunotherapy and Anti-Angiogenic Therapies in HNSCC